United States, Jan. 26 -- Voisin Consulting Life Sciences (VCLS), a well-established contract research organization (CRO) with a focus on unmet medical need and rare drug clinical trials, has chosen Oracle Argus to significantly enhance its global pharmacovigilance operations. By choosing Argus, VCLS will gain proven tools to enhance and deliver comprehensive, end-to-end pharmacovigilance services to its diverse global clientele. VCLS chose Oracle Argus for its comprehensive capabilities, industry leadership, and proven track record. Oracle Argus solution will help VCLS strengthen its safety services and meet complex sponsor requirements to support a wide array of clients.
Published by HT Digital Content Services with permission from Pivot...